Previously, genome-wide mRNA expression profiling studies by us and others have demonstrated that EPHA4 is highly upregulated in SS cells compared to other cutaneous lymphomas, such as mycosis fungoides (MF), benign forms of erythroderma and healthy controls [11–13]. This evidence concerns the gene EPHA4 and exfoliative dermatitis.